Pharmaceutical Guidelines

Quality Assurance (QA) in the Pharmaceutical industry, is very essential for ensuring that Pharmaceutical Products are manufactured to a safe and consistent standard, and references with the guidelines, WHO, GMP are the main principles for pharmaceutical products.

Ads

Breaking

Ads

Wednesday 2 December 2020

Deviation Control Procedure SOP

 

1.0              OBJECTIVE:

To lay down the procedure for control of deviations when introduced for systems, process, materials, product, procedure or man material movement from current specification.

2.0              SCOPE:

This sop is applicable to all the deviations occurring in manufacturing and testing and also arising from malfunctioning of equipment at -------------

3.0              RESPONSIBILITY:

3.1              Each affected department is responsible for initiation of deviation report.

3.2              Concerned Section Head of the Department is responsible for investigation, identifying root cause and placing corrective action & preventive action.

3.3              QA is responsible for review and approval of the deviation report.

4.0              ACCOUNTABILITY:

4.1              Department Head / Head - Quality Assurance shall be accountable for the compliance of SOP.

5.0              PROCEDURE:

5.1              Any departure from ongoing approved and established procedures such as SOPs, STP, Process, Systems, standards and protocols etc.

5.2              Deviations shall be categorized in Minor & Major deviations depending upon the nature of deviation & extent of direct or indirect impact on the quality systems & product quality.

5.3              Deviation may be classified as Unplanned Deviation or Planned Deviation.

5.3.1        Unplanned Deviation may occur due to human error, Malfunctioning or breakdown of equipment or equipment failures, Utility or service failure or breakdown, power supply failures/ interruptions, Accident/ Mishap in the plant,   any other unforeseen situation. It can also be observed on shop floor i.e. during processing for e.g. Temperature of the area has gone out of limit. At that time Department In charge shall forward the Deviation Control Form to QA Head.

5.3.2        Planned Deviations are those which are planned prior to execution. Planned Deviation may be carried out only for quality improvements, yield improvement, safety reasons, better GMPs or Marketing requirements. Implementation of the planned deviation shall be done only after it is authorized by Production Head and QA Head.

5.4              The Quality Assurance department classifies the deviation as follow:

5.4.1        CRITICAL DEVIATION: A functional deviation i.e. deviation which is certain to Cause failure of product to fulfill its intended procedure.

5.4.2        MAJOR DEVIATION: A deviation that may cause failure of product to fulfill its intended purpose.

5.4.3        MINOR DEVIATION: Deviation that may not prevent the product from fulfills its intended purpose.

5.5              In case the deviation is critical nature it’s rejected straight away and same is sent back to head of department concerned.

5.6              If required, the deviation initiator and department head with Quality Assurance or Quality Control, along with any other department complete any agreed actions required to evaluate the impact of deviation.

5.7              The deviation shall be assessed by the quality assurance, and include consideration of any batches of product, intermediate or components which may be affected from a standpoint of patient safety or regulatory compliance.

5.8              Decision by above group is taken based on following i.e. past history i.e.

5.8.1        Stability studies on retention samples in products, having same or similar deviation etc.

5.8.2        Evaluation on the impact of deviation is based on the present scenario with retention to product, its specifications, process difficulties etc.

5.9              The Production Head must ensure that there are no deviation approved in the established processes, procedure and standards under normal operating conditions. In case if any deviation occurs, it shall be immediately (24 hour) brought to the notice of QA Head for immediate appropriate action taken. The stage of operation, nature of deviation and the reason for deviation shall be recorded in the deviation report. No deviation shall be permitted from pharmacopoeia and other regulatory specifications.

5.10          Once the impact of deviation is evaluated and accepted, the Document Issuance Requisition shall be approved by applicable Department Head or his designee and authorized by QA Head or his designee.

5.11          QA Officer / Executive shall receive the request for deviation form in Document Issuance Requisition Format No. F/QA-013-01 duly signed with reason for the issuance.

5.12          After the authorization of requisition by QA Head or his designee, submit the request to quality assurance officer/executive shall allocate the unique requisition number as per following procedure.

The Document Issuance requisition shall be numbered as – PD/@@/XXYYY

Where PD indicates the type of deviation (i.e. PD indicates for Planed deviation & UD indicates for unplanned deviation).

@@ indicates the name of the Originating department.

Codes for individual department shall be as follows –

Sr. no.

Department

Code No.

0.1

Quality Assurance

QA

2.0

Quality Control

QC

3.0

Engineering

EG

4.0

Personnel & Administration

PA

5.0

Production

PD

6.0

Ware house (RM/PM)

WH

7.0

Finished Goods

FG

 

 

           

 

 

 

 

XX- Year of deviation like 18 for the current year,

YYY – Serial Number of the deviation

5.13          Each deviation report shall be filled as per the Format No. F/QA-011-01 issued from QA and recorded in Log book Format No.: F/QA-011-02. In case of Loan License Party’s/QA Third party if required, the deviation report is filled in the form provided by the respective Party.

5.14          Planned deviation shall be previously approved by the other departments concerned with the deviation for e.g. Production, Quality Control, Warehouse, Maintenance, Personnel and Administration, Accounts, Marketing or the Quality Assurance Department of Loan Licence/QA Third party if applicable, Quality Head and QA Head whereas unplanned deviation shall be brought into their notice and approval shall be taken.

5.15          If in any case deviation not closed timely then give the reason and justification for extension date of deviation extension period as per format number F/QA-011-01.

5.16          QA Head shall review the deviation and shall evaluate its impact on the product quality attributes in consultation with Production manager.

5.17          If the deviation does not affect product quality, QA Head shall allow further processing of the batch in question.

5.18          If there are likely chances of product quality getting affected, QA Head shall not allow further processing of the batch. Product shall be “quarantined” in sealed container. Container shall be labeled, indicating product name, Batch number, manufacturing date. The labeled containers shall be kept in secured area under lock & key.

5.19          The QA Head along with the Production manager & maintenance manager shall investigate & find out the root cause of the problem that results in the process deviation. Based on the root cause, preventive action plan to avoid reoccurrence shall be decided & implemented. In case of unplanned deviation and comments including the steps to avoid such deviations in future shall be recorded in the Deviation Control Form. In case of unplanned deviation copy of investigation report shall be attached and for planned deviation justification shall be provided.

5.20          The report shall be forwarded to quality assurance head /designee. After reviewing the nature of deviation and its impact on product quality, identity, strength and purity shall decide upon the future course of action(s), which could be

5.20.1    Reprocessing or

5.20.2    Rejection of batch

5.21          QA Head shall inform Plant Head/ Production Head regarding the disposition of the batch under deviation and also shall decide about the requirement of carrying out any additional test, controls, sampling and stability studies.

5.22          Reprocessing product shall be released only if the product meets all its approved specifications. Past experience on similar deviations or past validation data shall be referred for taking the decision.

5.23          Based on the above review QA Head shall give their recommendation including the steps to avoid such deviation in future and additional testing of the product if required. The results of studies carried out in support of process validation or any past incidences of similar nature may be used for taking the decision on deviation under consideration.

5.24          After getting the decision from QA Dept it will be reflected on the format number F/QA/013-02. The approved photocopy of the Deviation Control Form shall be filed in the respective Batch Manufacturing Record and the original copy shall be retained by the QA Head in Deviation Control Form File. In case if a deviation is recurring with respect to some material, which may affect more than one production batches, photocopies shall be filed in every Batch Manufacturing Records of the other affected batches.

5.25          After implementation of corrective action / preventive action as per the deviation QA person verified the result of effectiveness of the result. Impact of Deviation shall be assessed and compliance ensured with aspect to various recommendations made in the Deviation Control Form. Then only QA Head/designee shall finally close out the deviation .All investigation shall be completed within a time period of 30 days except if approval /data waiting from the party.

5.26          Every Deviation Control Form shall be approved/ rejected and closed within a time frame of 30 days after investigation except in cases where decision is pending from party.

5.27          Repetition of same type of deviation should be recorded and take the corrective action.

5.28          Review the Deviations log book on yearly basis with a goal to look for trends as common problems as per Annexure number A/QA-011-05. Inform to QA Head about review findings.

5.29          Any amendments to systems, documents or operating procedures arising out of the recommendations for corrective and preventive actions shall be done according to the sop for ‘Change Control’.

5.30          Acceptance Criteria:

            Every Change Control Form should be closed within its specified time period after final authorization.

5.31          Frequency: As per requirement.

6.0              LIST OF ANNEXURE AND FORMATS:

Sr. No.

Title of Format

Format No.

01

Deviation Form

F/QA-011-01

02

Deviation Control Log

F/QA-011-02

03

Planned deviation flow chart

F/QA-011-03

04

Un-Planned deviation flow chart

F/QA-011-04

05

Trending of Deviation

F/QA-011-05

7.0              REFERENCE:

7.1              SOP-QA-001

7.2              F/QA-001-01

7.3              SOP-QA-014

8.0              REVISION HISTORY:

Sr. No.

Date

Reason for Revision

Revision No

1.          

31/10/2018

New SOP

R0

2.          

31/10/2020

Schedule Revision

R1

9.0              ABBREVIATIONS:

Sr. No

Abbreviations

Details

01

GMP

Good manufacturing practice

02

EHS

Environmental Health And Safety

03

QA

Quality assurance

04

DEPT.

Department

05

SOP

Standard operating procedure

END OF DOCUMENT


DEVIATION FORM NO.:  ________________________                                     DATE: ______________________

(To be filled by QA dept.)

 

Short Description of Deviation:

 

 

 

DEVIATION OCCURRED IN :

(Put a tick mark)   □ Man                      Mother Environment

   

                              □ Material                Method

 

                              □ Machine               Measurement

TYPE OF DEVIATION.

(Put a tick mark)          

                            

               □ Planned

 

               □ Unplanned                                               

 

 

 

DETAILS :

Product / Material / Equipment / Document / Record Name

 

Batch Size / Quantity

 

Batch No. / A.R.No. / I.D.No.

 

G.R.No.

 

Mfg. Date

 

Supplied By

 

Exp. Date

 

Any other information

 

 

DESCRIPTION OF THE DEVIATION :

 

 

 

 

 

 

 

 

DESCRIPTION OF STANDARD PRACTICE:      

 

 

 

 

 

 

 

IMPACT ASSESSMENT:

 

 

 

 

 

 

 

 

           (Initiator Name, Sign & Date)                                     (HOD/Designee Name, Sign & Date)

(Initiating Department)                                               (Initiating Department)

 

OTHER AFFECTED DEPARTMENTS COMMENT / APPROVAL (As Applicable) :

DEPARTMENT

COMMENTS / APPROVAL

SIGN. / DATE

Production

 

 

Quality Control

 

 

Warehouse

 

 

Maintenance

 

 

Personnel and Administration

 

 

Account

 

 

Marketing

 

 

QA of Loan licensee

 

 

Any Other department

 

 

 

Number of Repeated Deviation in last Six Months: _____________________________________________

(To be filled by QA)

 

Critical Deviation

A functional deviation i.e. deviation which is certain to cause failure of product to  fulfill its intended procedure

Major Deviation

A deviation that may cause failure of product to fulfill its intended purpose

Minor Deviation

Deviation that may not prevent the product from fulfill its intended purpose

 

 

 

 

INITIATION APPROVAL FOR DEVIATION:

 

DEPARTMENT

NAME

DESIGNATION

REMARK (APPROVED/

REJECTED/MORE INFORMATION)

SIGN / DATE

QUALITY ASSURANCE HEAD/ DESIGNEE

 

 

 

 

 

INVESTIGATION FOR DEVIATION :

 

By QA and Dept. Head

(Attach extra sheet)

 

 

 

 

 

 

 

 

 

 

 

Root Cause:

 

 

 

 

 

 

 

 

Prepared by :                                Date :                              Reviewed by :                                          Date:-       

           

 

 

Reason and Justification  for Extension Date of the Deviation (If applicable):

 

REASON AND JUSTIFICATION FOR DELAY:

 

 

 

 

 

TENTATIVE EXTENSION DATE: ____________________

 

INITIATOR NAME SIGN/DATE:  ________________________________________                                                                                                              

 

COMMENT/APPROVAL FROM QA:

 

 

 

 

 

QA HOD/DESIGNEE NAME, SIGN & DATE:_______________________________

 

QUALITY ASSURANCE REVIEW  :

 

(Additional work required, if any) 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                                                                                                                                       

                                                                                                                                                         Reviewed By

                                                                                                                                                          Sign/Date

 

 

 

CLOSURE OF THE DEVIATION:

 

The approved deviation have been implemented /not implemented satisfactory. The deviation can be closed.

 

Close out date of the deviation after evaluation: _____________________

 

DEPARTMENT

NAME

DESIGNATION

REMARK

(CAPA NO. if required)

SIGN / DATE

QUALITY ASSURANCE HEAD/DESIGNEE

 

 

 

 

 

 

 

 

Deviation Req. No.

Date

Initiating Dept.

Deviation Req. by

(Sign/Date)

Description of Deviation

Material/Product name (if applicable)

 

Conclusion (Approved / Rejected)

 

Initial approval by Sign /date

Close Out

Date after confirmation

Final authorization

Sign /date

Remark

Item/Product Name

Batch No/

A.R. NO

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


No comments:

Post a Comment

Pharmaceutical guideline only